Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria, Falciparum | 22 | 2024 | 220 | 3.250 |
Why?
|
| Plasmodium falciparum | 22 | 2024 | 246 | 2.690 |
Why?
|
| Antimalarials | 12 | 2024 | 124 | 2.010 |
Why?
|
| Drug Resistance | 12 | 2024 | 149 | 1.630 |
Why?
|
| Malaria | 5 | 2024 | 148 | 0.890 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 313 | 0.590 |
Why?
|
| Uganda | 8 | 2024 | 56 | 0.390 |
Why?
|
| Mutation | 4 | 2020 | 2607 | 0.390 |
Why?
|
| Folic Acid Antagonists | 2 | 2022 | 8 | 0.370 |
Why?
|
| Democratic Republic of the Congo | 4 | 2020 | 19 | 0.270 |
Why?
|
| Sulfadoxine | 4 | 2020 | 15 | 0.270 |
Why?
|
| Genome, Protozoan | 2 | 2024 | 13 | 0.270 |
Why?
|
| Plasmodium ovale | 1 | 2024 | 7 | 0.230 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2024 | 17 | 0.230 |
Why?
|
| Bacillus thuringiensis | 1 | 2024 | 20 | 0.220 |
Why?
|
| Protozoan Proteins | 5 | 2024 | 126 | 0.220 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2024 | 16 | 0.220 |
Why?
|
| Proviruses | 1 | 2024 | 27 | 0.220 |
Why?
|
| Hemolysin Proteins | 1 | 2024 | 44 | 0.220 |
Why?
|
| Endotoxins | 1 | 2024 | 81 | 0.210 |
Why?
|
| Introns | 1 | 2024 | 111 | 0.210 |
Why?
|
| Artemisinins | 2 | 2021 | 38 | 0.210 |
Why?
|
| Parasites | 1 | 2023 | 16 | 0.210 |
Why?
|
| Culicidae | 1 | 2023 | 12 | 0.210 |
Why?
|
| Thermogenesis | 1 | 2024 | 121 | 0.210 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 118 | 0.200 |
Why?
|
| Humans | 26 | 2024 | 63292 | 0.200 |
Why?
|
| Genotype | 5 | 2024 | 664 | 0.200 |
Why?
|
| RNA, Viral | 1 | 2024 | 276 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2024 | 193 | 0.200 |
Why?
|
| Proteasome Inhibitors | 1 | 2022 | 31 | 0.200 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 50 | 0.180 |
Why?
|
| Aminoquinolines | 1 | 2021 | 16 | 0.180 |
Why?
|
| Naphthoquinones | 1 | 2021 | 6 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 1 | 2023 | 226 | 0.180 |
Why?
|
| Dendritic Cells | 1 | 2024 | 524 | 0.180 |
Why?
|
| Pyrimethamine | 4 | 2022 | 20 | 0.170 |
Why?
|
| Chloroquine | 4 | 2021 | 61 | 0.170 |
Why?
|
| Drug Combinations | 4 | 2021 | 165 | 0.160 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2024 | 426 | 0.160 |
Why?
|
| Genome, Viral | 1 | 2020 | 136 | 0.160 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 73 | 0.160 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 322 | 0.150 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2020 | 103 | 0.150 |
Why?
|
| HIV-1 | 1 | 2024 | 721 | 0.150 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 196 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 766 | 0.150 |
Why?
|
| Microsatellite Repeats | 1 | 2018 | 41 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2024 | 796 | 0.140 |
Why?
|
| Tanzania | 3 | 2024 | 37 | 0.140 |
Why?
|
| Whole Genome Sequencing | 3 | 2024 | 81 | 0.140 |
Why?
|
| Child | 4 | 2021 | 4522 | 0.140 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 677 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2018 | 206 | 0.130 |
Why?
|
| Haplotypes | 3 | 2022 | 131 | 0.130 |
Why?
|
| Genetic Variation | 3 | 2024 | 383 | 0.120 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 48 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2015 | 319 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1199 | 0.110 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 2024 | 22 | 0.110 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2024 | 14 | 0.100 |
Why?
|
| Prevalence | 3 | 2021 | 1380 | 0.100 |
Why?
|
| Zambia | 2 | 2023 | 17 | 0.100 |
Why?
|
| Drosophila | 1 | 2015 | 435 | 0.090 |
Why?
|
| Proguanil | 2 | 2022 | 6 | 0.090 |
Why?
|
| Gene Frequency | 2 | 2023 | 123 | 0.090 |
Why?
|
| Infant | 3 | 2020 | 1649 | 0.090 |
Why?
|
| Geography | 2 | 2021 | 38 | 0.090 |
Why?
|
| Genomics | 2 | 2024 | 370 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2020 | 1988 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2674 | 0.080 |
Why?
|
| Female | 6 | 2023 | 32787 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 696 | 0.080 |
Why?
|
| Adolescent | 4 | 2021 | 6238 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2571 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1184 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2015 | 685 | 0.070 |
Why?
|
| Male | 5 | 2021 | 29814 | 0.070 |
Why?
|
| Animals | 5 | 2024 | 20631 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1254 | 0.060 |
Why?
|
| Africa South of the Sahara | 1 | 2024 | 20 | 0.060 |
Why?
|
| Insecticide Resistance | 1 | 2024 | 10 | 0.060 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2024 | 24 | 0.060 |
Why?
|
| Metagenomics | 1 | 2024 | 28 | 0.060 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2024 | 12 | 0.060 |
Why?
|
| Citric Acid Cycle | 1 | 2024 | 28 | 0.060 |
Why?
|
| Karyopherins | 1 | 2024 | 7 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2024 | 93 | 0.060 |
Why?
|
| Piperazines | 1 | 2024 | 81 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 3285 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2023 | 12 | 0.050 |
Why?
|
| Phylogeny | 1 | 2024 | 376 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2024 | 200 | 0.050 |
Why?
|
| Ligases | 1 | 2023 | 28 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 122 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2023 | 29 | 0.050 |
Why?
|
| Ethylenediamines | 1 | 2022 | 2 | 0.050 |
Why?
|
| Asparagine | 1 | 2022 | 25 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2023 | 82 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 126 | 0.050 |
Why?
|
| Ethiopia | 1 | 2021 | 8 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 206 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 429 | 0.050 |
Why?
|
| Cytochromes b | 1 | 2021 | 4 | 0.040 |
Why?
|
| Atovaquone | 1 | 2021 | 5 | 0.040 |
Why?
|
| Cambodia | 1 | 2021 | 27 | 0.040 |
Why?
|
| Antigens, Protozoan | 1 | 2021 | 56 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2022 | 191 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2021 | 83 | 0.040 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2020 | 10 | 0.040 |
Why?
|
| Molecular Probes | 1 | 2020 | 31 | 0.040 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2020 | 19 | 0.040 |
Why?
|
| Parasitemia | 1 | 2020 | 47 | 0.040 |
Why?
|
| Kenya | 1 | 2020 | 92 | 0.040 |
Why?
|
| Ghana | 1 | 2020 | 14 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 4683 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 60 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 308 | 0.040 |
Why?
|
| Islands | 1 | 2020 | 2 | 0.040 |
Why?
|
| Haploidy | 1 | 2020 | 11 | 0.040 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2020 | 19 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2019 | 6 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 13 | 0.040 |
Why?
|
| Travel | 1 | 2020 | 42 | 0.040 |
Why?
|
| Gene Library | 1 | 2020 | 102 | 0.040 |
Why?
|
| Demography | 1 | 2020 | 173 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2020 | 232 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 255 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 16782 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 134 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 413 | 0.040 |
Why?
|
| Peptides | 1 | 2022 | 574 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 1465 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2020 | 262 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 359 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 768 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 491 | 0.030 |
Why?
|
| Phenotype | 1 | 2021 | 1200 | 0.030 |
Why?
|
| HIV Infections | 1 | 2024 | 967 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2024 | 1514 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1375 | 0.030 |
Why?
|
| Larva | 1 | 2015 | 139 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 94 | 0.030 |
Why?
|
| Neuroglia | 1 | 2015 | 79 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 300 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2330 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2568 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2023 | 3033 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 640 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 10827 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1539 | 0.020 |
Why?
|
| Brain | 1 | 2015 | 1555 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 17549 | 0.010 |
Why?
|